Political uproar in India after Astrazeneca admits blood clot side effect

A political controversy has erupted in India after British pharma giant Astrazeneca admitted in the UK court that it's Covid-19 vaccine to blood clots in "very rare cases".

The company's statement came after 51 lawsuits accused the vaccine of being "defective" and leading to serious injury and death.

Watch in for more details!